US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy

Regulations by 2FIRSTS, edited by Sophia
May.06.2024
US States Enact E-Cigarette Bans, PMTA Registry Bills Trigger Controversy
Virginia bans flavored e-cigarettes, Iowa still undecided. Critics argue laws harm smoking cessation options. Major economic impact expected.

According to overseas media FilterMag, on May 2nd, it was reported that flavored e-cigarettes will be banned in the state of Virginia, but the ban will not take effect until one year later. Meanwhile, the decision on similar legislation in Iowa is pending the governor's signature or veto. These are just the latest PMTA registration laws, which are increasingly spreading across the United States under the guise of protecting consumers from unregulated products. Critics argue that these laws harmfully restrict people's options for quitting smoking.

 

Iowa Governor Kim Reynolds has not indicated whether she will sign a bill passed by the legislature in April. The Consumer Advocates for Smoke-free Alternatives Association (CASAA) has dubbed it the "Big Tobacco Protection Act." In Virginia, lawmakers also recently passed a registration bill, which Governor Glenn Youngkin (R) approved but with an amendment to delay implementation until July 1, 2025. The bill was passed by the legislature in April.

 

Oklahoma, Louisiana, and Alabama have implemented the PMTA registration legislation, according to Ecigator reports. While laws in Kentucky, Utah, and Wisconsin are set to take effect by 2025 (though there is ongoing litigation against the legislation in Kentucky), a report states that "legislators in about 20 other states are currently considering similar bills.)

 

According to advocates for harm reduction in tobacco, banning flavored e-cigarettes will only lead consumers to turn to the illegal market or even revert back to traditional cigarettes. Research also indicates that the choice of flavors is highly important for individuals transitioning from cigarettes to e-cigarettes.

 

However, tobacco companies that are actively promoting the above-mentioned legislation have a different perspective on this. They believe that these laws will help combat the illicit tobacco market and ensure that all kinds of businesses accept products authorized by the U.S. Food and Drug Administration (FDA).

 

Critics of these bills argue that small businesses and individuals trying to quit smoking will suffer. More than 1,800 people in Virginia could lose their jobs, and the state could lose over $250 million in economic benefits. Small businesses will also face fines of $1,000 per day for each unapproved product they sell. While tobacco giants are advocating for the ban, the public is skeptical of their motives.

 

Most legislators do not understand that the purpose of the PMTA registration is to ban the sale of the majority of e-cigarette products intended for use by adults in this state.

 

The FDA is facing harsh criticism from tobacco harm reduction advocates for denying millions of PMTA applications. They argue that the barriers to submission are so high that only the largest companies with significant financial and scientific resources have a chance at authorization.

 

However, one of the sponsors of the legislation, Virginia Delegate Rodney Willett (D-Henrico), said that despite the lengthy challenge, the FDA's program is important because a large number of e-cigarette products from China are flooding in, which he referred to as being "largely unregulated and untaxed in most cases." Willett believes, "Most legislators do not understand that the purpose of PMTA registration is to ban the sale of the vast majority of e-cigarette products used by adults in this state." "They think they are fighting against villains from China, but in reality, they are making the lives of their own constituents worse."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands (TPB) reported third-quarter 2026 Modern Oral net sales of $74.4 million on November 9, up 102.9% year over year and representing 49.2% of consolidated net sales. Total company net sales rose 27.0% to $151.1 million, while net income attributable to TPB declined 81.4% to $3.93 million. The company is expanding the US retail presence of its FRE and ALP nicotine pouch brands and expects its Modern Oral chain-store footprint to grow by more than 70% during 2026. Selling, general and administrative expenses increased 69.1% to $75.3 million, while PMTA-related expenses reached approximately $3.15 million and manufacturing start-up costs totaled about $593,000. ALP plans to open a branded pop-up in New York City's SoHo neighborhood on November 13, alongside a marketing campaign extending into January 2027. TPB owns 50% of ALP but consolidates the venture in its financial statements.
company
Nov.11
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Azerbaijan's sweeping e-cigarette ban has raised concerns over enforcement errors and the emergence of illicit sales, while neighboring Armenia is tightening technical rules and preparing higher excise taxes. Georgia, meanwhile, has resisted calls for broader vape restrictions and introduced preferential taxes for some domestically produced cigarettes. The divergent approaches across the South Caucasus highlight a regional policy dilemma: how to curb nicotine use and protect public health without encouraging black markets or creating unintended economic consequences for businesses and consumers.
Nov.03
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italian Financial Police Seize 4.3 Million E-Cigarettes and Smoking Accessories; 28 Reported to Judicial Authorities Across Operations
Italy's Guardia di Finanza announced on October 28 that officers in Latina province had seized approximately 4.3 million e-cigarettes and smoking accessories at an unauthorized warehouse in an operation involving restrictions on the possession and sale of tobacco-related products. Another 300,000 suspected counterfeit or unsafe items were confiscated during separate inspections, bringing total seizures across the operations to more than 4.6 million products. Twenty-eight people were reported to judicial authorities over suspected smuggling and counterfeiting offenses. Officials did not disclose separate vape quantities, the value of the merchandise or alleged violations associated with individual brands.
Enforcement
Oct.29
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
Product|AIR Files U.S. PMTA for Crown Switch. Can Greentank's Chip Technology Deliver a Compliance and Competitive Advantage?
Product|AIR Files U.S. PMTA for Crown Switch. Can Greentank's Chip Technology Deliver a Compliance and Competitive Advantage?
AIR Global PLC (NASDAQ: AIIR) announced on November 5, 2026, that it had submitted a Premarket Tobacco Product Application (PMTA) to the U.S. Food and Drug Administration (FDA) for Crown Switch, its rechargeable pod vape platform. First launched in Germany in November 2025, the device uses Quantum Chip atomization technology developed by Canadian vaporization technology company Greentank Innovations. German retail versions feature 2mL prefilled pods containing 18mg/mL nicotine in six flavors, while AIR has separately tested two 5% nicotine formulations intended for U.S. development. AIR invested $20 million in Greentank in July and reported approximately $3.4 million in U.S. PMTA-related regulatory costs for the first nine months of 2026. The Crown Switch application has been submitted, but the FDA has not granted marketing authorization.
product
Nov.13